Stimcell Energetics (STME) Interest Coverage Ratio (QoQ) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -147.38% |
| Feb 29, 2024 | -149.86% |
| Nov 30, 2023 | -20.05% |
| Aug 31, 2023 | 55.54% |
| May 31, 2023 | 48.35% |
| Feb 28, 2023 | 30.03% |
| Nov 30, 2022 | 18.10% |
| Aug 31, 2022 | 17.82% |
| May 31, 2022 | -10.83% |
| Feb 28, 2022 | 47.52% |
| Nov 30, 2021 | 33.96% |
| Aug 31, 2021 | -129.67% |
| May 31, 2021 | -9.80% |
| Feb 28, 2021 | 18.29% |
| Nov 30, 2020 | 23.77% |
| Aug 31, 2020 | 29.29% |
| May 31, 2020 | 23.11% |
| Feb 29, 2020 | 29.86% |
| Nov 30, 2019 | -131.09% |
| Feb 28, 2019 | -28.30% |
| Nov 30, 2018 | -58.08% |
| May 31, 2017 | 100.34% |
| Feb 28, 2017 | -270.57% |
| Nov 30, 2016 | -158.54% |
| Aug 31, 2016 | 31.93% |
| May 31, 2016 | 24.21% |